Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

RayStation 10B: Brachytherapy Planning and a Speed Revolution in Proton Monte Carlo Dose Computation

RaySearch Laboratories AB (publ) has launched the latest release of its widely adopted treatment planning system. RayStation®* 10B adds support for brachytherapy planning and a new GPU Monte Carlo algorithm, which typically cuts final dose computation times to less than five seconds. In line with the company’s aim of integrating with as many treatment delivery systems as possible, the new release includes support for high-dose-rate (HDR) brachytherapy planning. RayStation 10B features automatic channel reconstruction in combination with powerful dwell-time optimization, enabling

Share buy-backs in Tethys Oil

During the period 18 – 22 December 2020, Tethys Oil AB (publ) has repurchased a total of 106,070 of its own shares. The buy-back program, which was announced on 11 December 2020, is being conducted in accordance with the EU Market Abuse Regulation No 596/2014 and the Commission Delegated Regulation No 2016/1052.Date Aggregated Weighted average Total daily daily share price per day transaction value volume (SEK) (SEK) (number of shares)18 20,538 50.75 1,042,373December2020

Nixu Corporation: Announcement of a change in shareholding according to Chapter 9, Section 10 of the Finnish Securities Market Act

Nixu Corporation, Stock exchange release on December 23, 2020 at 16.25Nixu Corporation has received a notification pursuant to Chapter 9, Section 5 of the Securities Markets Act from Handelsbanken Fonder AB on December 23, 2020. According to the notification the holding of Handelsbanken Fonder AB in the Company’s shares (ISIN: FI0009008387) has decreased under 5% on December 22, 2020. Nixu has one share series and each share entitles its holder to one (1) vote. The total number of shares is 7,425,219. Total positions of Handelsbanken Fonder AB: % of % of

RaySearch Brings Data-Driven Oncology to Cancer Clinics Worldwide with RayIntelligence

RaySearch Laboratories AB (publ) announces the launch of RayIntelligence – an advanced new software system designed to enable healthcare providers to generate actionable insights from their real-world data. Data-driven oncology represents a new era in healthcare by enabling cancer clinics to collect, structure and analyze data, for improved decision making. RayIntelligence is the latest addition to a growing portfolio of advanced software solutions from RaySearch. The aim is to empower cancer clinics to reach new levels of personalization in the care they provide using insights

Moberg Pharma’s rights issue of MSEK 150 is fully subscribed and no issue guarantees have been used

The Board of Directors of Moberg Pharma AB (publ) (OMX: MOB) (“Moberg Pharma” or the “Company”) today announces the outcome of the fully guaranteed rights issue of units with preferential rights for Moberg Pharma’s shareholders (the “Rights Issue”) which was resolved upon by the Board of Directors on November 6[th], 2020 and approved by an extraordinary general meeting on December 1[st], 2020. In total, 16,434,319 units were subscribed for with support of unit subscription rights, corresponding to approximately 71 percent of the Rights Issue. The remaining 6,741,257 units, corresponding to

Insplorion's Nomination Committee for the 2021 Annual General Meeting has been appointed

The Nomination Committee consist of Mikael Hägg, Elin Langhammer and Fredrik Sanell. The Chairman of the Nomination Committee is Mikael Hägg, who can be reached on +46(0)727-17 17 11.In accordance with the decision of the Annual General Meeting, the company's Nomination Committee for the 2021 Annual General Meeting shall consist of three members. After the end of the third quarter, the Chairman of the Board contacted the five largest shareholders then entered in the share register and, in consultation with them, appointed three members, who shall constitute the Nomination Committee. This

Projektengagemang Sweden AB (publ) extends credit agreement

Projektengagemang Sweden AB (publ) has extended its existing agreement with SEB regarding a credit facility. The facility is extended to 27 November 2020 and consists of term loans, acquisition credit and overdraft facilities, with a total credit facility of SEK 349 million. The terms are mainly unchanged. Undrawn credit facility as of 30 September 2020 was SEK 160 million.– Along with the good results during the first nine months, the extended agreement provides financial strength and creates further stability going forward, says Peter Sandberg, CFO.  INFORMATION THAT PROJEKTENGAGEMANG

Company Announcement no. 120, 2020 - Fixing of coupons with effect as from 1 January 2021

The coupons for the FRNs listed below will change taking effect 1 January 2021. The new coupons will be in force from 1 January 2021 – 30 June 2021. FRNs without interest rate cap, CITA6, ISIN-codes:                       DK0002044395, maturity 2022, new coupon as per 1 January 2021:                     -0.16% p.a.DK0002041458, maturity 2023, new coupon as per 1 January 2021:                     -0.04% p.a. FRNs without interest rate cap, CIBOR6, ISIN-codes:DK0002038587, maturity 2021, new coupon as per 1 January 2021:                     -0.23% p.a.DK0002041532, maturity 2022,

Webstep signs framework agreement with the Norwegian Courts Administration

The agreement has a duration of four years and represents an estimated sales value of approximately NOK 100 million. The purpose of the framework agreement is to secure competence and capacity to realise the strategy of the Norwegian Courts Administration to digitise its operations.The agreement is part of a digital transformation of the case management systems in the Norwegian Courts Administration. In this process, Webstep will be responsible for the Java based applications and work as an integral part of the Norwegian Courts Administration’s IT organisation. “We are very pleased to be

Audientes implements an incentive and retention program for parts of the management and senior full-time employees

The purpose of the program is to maintain the employment of professional and valuable resources in the company, and to provide an incentive for them to make a special effort for the value creation of the company. Announcement no. 4-2020In accordance with the company’s IPO company description, the Board of Directors has today decided to implement an incentive and retention program to parts of the management and a number of full-time employees. The program consists of granting 490,000 warrants, which gives the right to a subscription of 490,000 shares in the company with an exercise price of

Catena Media repurchases bonds of a total nominal amount of EUR 2,268,000

Catena Media plc (Nasdaq Stockholm: CTM) Catena Media plc (“Catena Media” or the “Company”) today announces that the Company has repurchased bonds of its up to EUR 250,000,000 senior unsecured (and from 31 January 2021, secured) callable floating rate bonds (ISIN: SE0010832154) (the “Outstanding Bonds”), governed by the terms and conditions originally dated 2 March 2018 and as amended and restated on 29 June 2020 (the “Terms and Conditions”).Pursuant to Clause 11.2 of the Terms and Conditions (The Group Companies’ purchase of Bonds), Catena Media today announces that it has repurchased

BioStock: Ultimovacs initiates fourth phase II trial with UV1

Christmas came a few days early for Ultimovacs as the company was able to announce the initiation of its fourth phase II trial with universal vaccine UV1. The combination study, aimed at head and neck cancer patients indicated to receive checkpoint inhibitor pembrolizumab, will be conducted at 10 sites across Germany and led by renowned principal investigator Prof. Mascha Binder, M.D.Read the full article at biostock.se: https://www.biostock.se/en/ultimovacs-initiates-fourth-phase-ii-trial-with-uv1/ This is a press release from BioStock - Connecting Innovation & Capital.

Shenzhen proton therapy treatment center selects C-RAD Catalyst™ system

C-RAD has now received the purchase order from the Belgium company Ion Beam Applications SA (IBA), regarding the supply of C-RAD’s surface tracking solution for Shenzhen proton therapy center. The purchase order includes multiple Catalyst™ systems and a Sentinel™ 4DCT system including a multiyear service agreement. In June 2020 C-RAD and IBA signed a letter of Intent for the supply of the Catalyst and Sentinel systems for this project. Since June C-RAD and IBA worked on the supplier evaluation process. The successful finalization was a pre-requisite for the purchase agreement.

Penneo A/S signs first customer in Finland

Company Announcement No. 12-2020Copenhagen, December 23rd, 2020 Penneo A/S signs first audit and accounting customer, Accado, in Finland. The new contract is in alignment with the strategy to roll out Penneo's platform internationally and to focus on audit and accounting companies. Penneo A/S’s CEO Nicolaj Højer Nielsen states: “We are very happy to onboard our first Finnish customer and satisfied that it happened just two months after going live in Finland. We have already seen good traction in the Finnish market since several of our existing non-audit clients have expanded their

Loudspring increases ownership in Eagle Filters, respirators pass requirements for first CE-certifications

Loudspring Oyj Company release, insider information 23.12.2020, 14:00 (EET)  Loudspring has entered into financing agreement with Eagle Filters and its founder Mr. Juha Kariluoto. The agreement includes capital investments, loan conversions as well as purchase options of existing shares. After the arrangement Loudspring has invested 2,5 million EUR more capital into Eagle Filters during 2020. In addition, Loudspring converts 1 million EUR previously existing loans to Eagle Filters into equity. As part of the transaction, Loudspring has also agreed on a purchase option to

Fellow Finance Plc financial reporting and annual general meeting in 2021

FELLOW FINANCE PLC COMPANY ANNOUNCEMENT 23.12.2020 AT 2:00 PMFellow Finance Plc will publish financial reports in 2021 as follows: The financial statements bulletin 2020 will be published on February 23, 2021 around 9.00 a.m. The half year financial report 2021 will be released on August 27, 2021 around 9.00 a.m. The annual report 2020 will be available on the company’s website on week 10. The annual general meeting is tentatively scheduled on March 31, 2021 in Helsinki at 2.00 p.m. The board of directors will summon the meeting later. Further enquiries Teemu Nyholm, CEO, Fellow

Vestas wins 138 MW repowering order in USA

News release from Vestas-American Wind TechnologyPortland, 23 December 2020 Vestas has received a 138 MW order to repower a wind project in the U.S.  With this order, Vestas will replace 73 existing V80-1.8 MW turbines with a total of 73 V110-2.0 MW turbines, including previously purchased 2 MW components. With the largest global installed capacity and service base, Vestas is uniquely positioned to harness operational and technical insights gained from the largest wind data repository in the world, to develop repowering solutions for Vestas and non-Vestas wind turbines alike.

Ideagen Plc Makes Largest Ever Acquisition with Purchase of Huddle

Ideagen Plc, the leading global provider of information management software for highly regulated industries, has today announced the acquisition of Huddle.Founded in 2006 Huddle has an established position as a leading supplier of SaaS based secure content collaboration and workflow solutions primarily in the UK and USA. Huddle provides cloud-based secure document collaboration and compliance software, which is complementary to Ideagen’s industry leading PleaseReview package. Huddle has around 380 customers, including a number of government departments in the UK and US, top names across

Key achievements in 2020 – an IndiTreat ® Launch year

Despite what has surely been a challenging year for all of us, both as private persons as well as companies big and small, 2020 has been a landmark year for 2cureX. September 2020 marked the official launch of our functional precision medicine tool, IndiTreat®.With 2020 coming to an end, I believe we are all breathing a sigh of relief, this year has been a year that dramatically influenced our everyday life and confronted all of us what it means when a Pandemic becomes a reality. However, for our company, 2020 marks also the reward of years of preparation, it marks the official launch of

SBB announces intention to launch a significantly enhanced voluntary tender offer to acquire Entra ASA

NOT FOR DISTRIBUTION, PUBLICATION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR SIMILAR ACTS. Press releaseStockholm / Oslo, 23 December 2020 SBB announces intention to launch a significantly enhanced voluntary tender offer to acquire Entra ASA SUMMARY HIGHLIGHTS · SBB announces its intention to launch a revised voluntary tender offer to acquire the entire share capital of Entra ASA (the “Enhanced

UPM Biochemicals grows lignin business with new Domtar supply agreement

(UPM, Helsinki, 23 December 2020 at 13:00 EET) – UPM and the US-based pulp and paper producer Domtar Paper Company LLC have signed an agreement for UPM to acquire the total annual kraft lignin production of Domtar’s Plymouth Mill in North Carolina, USA as of January 2021. This step enables UPM to expand its role in the growing lignin business and different application segments. Following the agreement, UPM will increase its supply of kraft lignin by more than 20.000 metric tonnes annually. Part of the supply will be used to complement the existing UPM BioPiva[TM] product family. UPM

NextCell Pharma’s rights issue was oversubscribed

NextCell Pharma AB ("NextCell" or the ”Company”) announces today the outcome in the Company’s new issue of shares with preferential rights for existing shareholders of approximately SEK 150 million (the “Rights Issue”). The Rights Issue was oversubscribed. Thus, no guarantees have been utilized.NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SOUTH AFRICA, SWITZERLAND, SINGAPORE OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR

K-Fastigheter acquires development property in Falkenberg

K-Fast Holding AB has entered into an agreement with Handelshuset de Roxen AB on the acquisition of land in Falkenberg Municipality. K-Fastigheter intends to develop a zoning plan for the Group’s concept buildings on the property, with rental apartments in an area with short distances to the city center, recreational area and water.K-Fast Holding AB (“K-Fastigheter”) has entered into an agreement to acquire the property Falkenberg Motorn 16, with address Sanddynevägen 42, in western Falkenberg. Underlying property value amounts to SEK 16.1 million with an expected gross area of 12,000

First delivery to Swedish patients with medical cannabis oil

STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER:  STENOSTENOCARE A/S (“STENOCARE”) and Emerald Health Therapeutics Inc (“Emerald”) hereby announces that the first shipment and delivery of medical cannabis oil has been completed on December 23, 2020 to Sweden.STENOCARE announced on September 8, that medical cannabis oil from their supplier, Emerald, had been accepted for treatment of Swedish patients. The Swedish and Canadian Health authorities has completed the required certificates and the first shipment of medical cannabis oil is now being delivered to the Swedish

There are no items matching the current filter
There are no more items matching the current filter
Back to top